ABCDEFGHIJKLMNOPQRSTUV
1
CompanyResearchScientific journalDateType of cooperationUniversityCountryScientist 1Scientist 2Scientist 3Scientist 4Scientist 5
2
Philip Morris/Vectura Fertin Pharma
Blood and urine multi-omics analysis of the impact of e-vaping, smoking, and cessation: from exposome to molecular responsess
Scientific reports (Nature)21/2/2014Research cooperationUniversity of Rochester Medical CenterUSALaurel BagliaRachel BergTimothy Curran
3
Philip Morris/Vectura Fertin Pharma
Nicotine-mediated effects in neuronal and mouse models of synucleinopathy
Frontiers Neuroscience31/8/2023Research cooperationUniversity of CaliforniaUSACassia Overk
Eliezer Masliah
4
Philip Morris/Vectura Fertin Pharma
Inactivation of SARS-CoV-2 on salt-coated surfaces: an in vitro study
Archives of microbiology30/6/2023Research cooperationUniversity of BerneSwitzerlandMonika Gsell Albert
5
Philip Morris/Vectura Fertin Pharma
Acclimation strategies of the green alga Chlorella vulgaris to different light regimes revealed by physiological and comparative proteomic analyses
Journal of experimental botany
17/8/2023Research cooperationUniversity of LiègeBelgiumClaire Remacle
6
Vectura
Δ9-Tetrahydrocannabinol (THC): A Critical Overview of Recent Clinical Trials and Suggested Guidelines for Future Research
Journal of clinical medicine07/03/2024Research cooperationThe University of Maine, University of South FloridaUSAPeter Pressman
Wallace Hayes
7
Vectura/Otitopic
Early assessment of the pharmacokinetic and pharmacodynamic effects following acetylsalicylic acid loading: toward a definition for acute therapeutic response
Journal of thrombosis and thrombolysis
Jan 2024Conflict of interestSinai Hospital of BaltimoreUSAPaul Gurbel
8
Vectura/Otitopic
Development of a routine bedside CYP2C19 genotype assessment program for antiplatelet therapy guidance in a community hospital catheterization laboratory
Journal of thrombosis and thrombolysis
Apr. 2024Conflict of interestSinai Hospital of BaltimoreUSAPaul Gurbel
9
Vectura
A systematic review and network meta-analysis of pharmaceutical interventions used to manage chronic pain
Scientific reports (Nature)18/1/2024Conflict of interestImperial CollegeUKArun Bhaskar
10
Vectura
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
The Lancet NeurologyMay 2024Conflict of interestUniversity Hospital of ToulouseFranceOlivier Rascol
11
Vectura
The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II
Frontiers in neurology23/8/2022Conflict of interestUniversity Hospital of ToulouseFranceOlivier Rascol
12
Vectura
Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial
BMC Neurology12/3/2022Conflict of interestUniversity Hospital of ToulouseFranceOlivier Rascol
13
Vectura
Operator-patient sex discordance and periprocedural outcomes of percutaneous coronary intervention (from the ORPKI Polish National Registry)
Advances in interventional cardiology
Jun 2023Conflict of interestMount Sinai School of MedicineUSARoxana Mehran
14
Vectura
Reply: The ROTA-CUT randomised trial: push the button harder
EuroIntervention19/2/2014Conflict of interestMount Sinai School of MedicineUSARoxana Mehran
15
Vectura
Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trial
EuroIntervention01/01/2024Conflict of interestMount Sinai School of MedicineUSARoxana Mehran
16
Vectura
Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized Trials
Circulation20/2/2024Conflict of interestUniversity of OklahomaUSARoxana Mehran
17
Vectura
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium
Circulation20/6/2023Conflict of interestUniversity of OklahomaUSARoxana Mehran
18
Vectura
Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis
Circulation. Cardiovascular interventions
Apr. 2023Conflict of interestUniversity of OklahomaUSARoxana Mehran
19
Vectura
Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions
Journal of the American College of Cardiology
22/8/2023Conflict of interestUniversity of OklahomaUSARoxana Mehran
20
Vectura
Comparison of Intravascular Imaging, Functional, or Angiographically Guided Coronary Intervention
Journal of the American College of Cardiology
5/12/2023Conflict of interestUniversity of OklahomaUSARoxana Mehran
21
Vectura
The Heart-Brain Connection in Myocardial Infarction in Women: A Dilemma to Tackle
Journal of the American College of Cardiology
24/10/2023
Conflict of interestUniversity of OklahomaUSARoxana Mehran
22
Vectura
Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial
American Journal of Cardiology
1/12/2023Conflict of interestUniversity of OklahomaUSARoxana Mehran
23
Vectura
US County-Level Variation in Preterm Birth Rates, 2007-2019
JAMA Open network1/12/2023Conflict of interestUniversity of OklahomaUSARoxana Mehran
24
Vectura
Implications of Social Disadvantage Score in Cardiovascular Outcomes and Risk Assessment: Findings From the Multi-Ethnic Study of Atherosclerosis
Circulation. Cardiovascular quality and outcomes
7/1/2023Conflict of interestJohns Hopkins Bloomberg School of Public HealthUSAMichael Joseph Blaha
25
Vectura
Incidental Coronary Artery Calcium on Chest CT in Persons Without Known Atherosclerotic Cardiovascular Disease
JAMA Internal medicine1/10/2023Conflict of interestJohns Hopkins Bloomberg School of Public HealthUSAMichael Joseph Blaha
26
Vectura
Type 2 Diabetes Mellitus: Now in the Cardiologist's Wheelhouse
Journal of the American College of Cardiology
17/10/2023
Conflict of interestJohns Hopkins Bloomberg School of Public HealthUSAMichael Joseph Blaha
27
Vectura
Lipoprotein(a), Residual Cardiovascular Risk, and the Search for Targeted Therapy
Journal of the American College of Cardiology
23/4/2024Conflict of interestJohns Hopkins Bloomberg School of Public HealthUSAMichael Joseph Blaha
28
Vectura
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial
American Heart Journal6/3/2024Conflict of interestUniversity of OklahomaUSADominick J. Angiolillo
29
Vectura
North American perspective on the 2023 European Society of Cardiology guidelines for the management of acute coronary syndromes
European Heart Journal. Acute cardiovascular care
9/02/2024Conflict of interestUniversity of FloridaUSADominick J. Angiolillo
30
Vectura
The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome
Journal of clinical medicine
25/03/2024
Conflict of interestUniversity of FloridaUSADominick J. Angiolillo
31
Vectura
Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk: The OPT-BIRISK Randomized Clinical Trial
JAMA Cardiology17/4/2024Conflict of interestUniversity of FloridaUSADominick J. Angiolillo
32
Vectura
Prehospital crushed versus integral prasugrel loading dose in STEMI patients with a large myocardial area
EuroIntervention1/4/2024Conflict of interestUniversity of FloridaUSADominick J. Angiolillo
33
Vectura
Long-term survival after cardiac arrest in patients undergoing emergent coronary angiography
Cardiovascular revascularization medicine
Mar. 2024Conflict of interestUniversity of FloridaUSADominick J. Angiolillo
34
Vectura
The Lipid-Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity
Thrombosis and haemostasis
19/3/2024Conflict of interestUniversity of FloridaUSADominick J. Angiolillo
35
Vectura
Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study
Thrombosis and haemostasis
Mar. 2024Conflict of interestUniversity of FloridaUSADominick J. Angiolillo
36
Vectura
One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial
EuroIntervention04/03/2024Conflict of interestUniversity of FloridaUSADominick J. Angiolillo
37
Vectura
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis
JAMA Cardiology20/3/2024Conflict of interestUniversity of FloridaUSADominick J. Angiolillo
38
Vectura
Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines
European Heart Journal. Acute cardiovascular care
September 2024Conflict of interestUniversity of FloridaUSADominick J. Angiolillo
39
Vectura
Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary Intervention
Circulation, cardiovascular interventions
April 2024Conflict of interestUniversity of FloridaUSADominick J. Angiolillo
40
Vectura
Optimizing LDL-cholesterol management in ACS patients: Breaking inertia and implementing intensified therapies
International Journal of Cardiology
1/4/2024Conflict of interestUniversity of FloridaUSADominick J. Angiolillo
41
Vectura
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review
Journal of the American College of Cardiology
23/1/2024Conflict of interestUniversity of Florida, Mount Sinai School of MedicineUSADominick J. Angiolillo
Roxana Mehran
42
Vectura
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial
JAMA Cardiology1/6/2021Conflict of interestUniversity of Florida, Mount Sinai School of MedicineUSADominick J. Angiolillo
43
Vectura
P2Y12 Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot Study
JACC Cardiovascular interventions
14/8/2023Conflict of interestUniversity of Florida, Mount Sinai School of MedicineUSADominick J. Angiolillo
44
Vectura
Clinical Pharmacokinetics and Pharmacodynamics of CSL112
Clinical PharmacokineticsApr. 2023Conflict of interestUniversity of Florida, Mount Sinai School of MedicineUSADominick J. Angiolillo
45
Vectura
The evaluation and management of coagulopathies in the intensive therapy units
European Heart Journal. Acute cardiovascular care
2/6/2023Conflict of interestUniversity of Florida, Mount Sinai School of MedicineUSADominick J. Angiolillo
46
Vectura
Long-Term Clopidogrel Monotherapy After Percutaneous Coronary Intervention: Will the Pupil Surpass the Master?
Journal of the American College of Cardiology
17/10/2023
Conflict of interestUniversity of Florida, Mount Sinai School of MedicineUSADominick J. Angiolillo
47
Vectura
Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study
JACC Cardiovascular interventions
23/10/2023
Conflict of interestUniversity of Florida, Mount Sinai School of MedicineUSADominick J. Angiolillo
48
Vectura
European practice patterns for antiplatelet management in NSTE-ACS patients: Results from the REal-world ADoption survey focus on Acute antiPlatelet Treatment (READAPT) survey
International Journal of Cardiology
1/9/2023Conflict of interestUniversity of Florida, Mount Sinai School of MedicineUSADominick J. Angiolillo
49
Vectura
DAPT guided by platelet function tests or genotyping after PCI: pros and cons
EuroIntervention18/9/2023Conflict of interestUniversity of Florida, Mount Sinai School of MedicineUSADominick J. Angiolillo
50
Vectura/Fertin Pharma
Migraine Prevalence, Environmental Risk, and Comorbidities in Men and Women Veterans
JAMA Network open4/3/2024Conflict of interestUniversity of CaliforniaUSANathaniel M Schuster
51
Vectura/Fertin Pharma
Debunking myths in headache diagnosis for the pain practitioner
Regional Anesthesia & Pain Medicine
10/10/2023Conflict of interestUniversity of CaliforniaUSANathaniel M Schuster
52
Vectura
Side effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort study
Scientific reports (Nature)02/2023Conflict of interestUniversity of RostockGermanyMicha Löbermann
53
Vectura
Automatic analysis of bronchus-artery dimensions to diagnose and monitor airways disease in cystic fibrosis
Thorax
21/09/2023
Conflict of interestErasmus MC Sophia Children's HospitalNLHarm Tiddens
54
Vectura
Bridging Treatment Implementation Gaps in Patients With Heart Failure: JACC Focus Seminar 2/3
Journal of the American College of Cardiology
8/8/2023Conflict of interestBaim Institute for Clinical ResearchUSAC. Michael Gibson
55
Vectura
Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma
BMJ Open respiratory research
May 2023Conflict of interestUniversity of Dundee School of MedicineUKBrian Lipworth
56
Vectura
Adrenal insufficiency in patients taking benralizumab as corticosteroid sparing therapy
The Lancet. Respiratory magazine
Jan 2022Conflict of interestUniversity of Dundee School of MedicineUKBrian Lipworth
57
Vectura
Repeatability of impulse oscillometry in patients with severe asthma
The European respiratory journal
31/12/2021
Conflict of interestUniversity of Dundee School of MedicineUKBrian Lipworth
58
Vectura
Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis
The Lancet. Respiratory magazine
Apr 2022Conflict of interestUniversity of Dundee School of MedicineUKBrian Lipworth
59
Vectura
Oscillometry bronchodilator response in adult moderate to severe eosinophilic asthma patients: A prospective cohort study
Clinical and experimental allergy
Sep 2022Conflict of interestUniversity of Dundee School of MedicineUKBrian Lipworth
60
Vectura
Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations
LungJun 2022Conflict of interestUniversity of Dundee School of MedicineUKBrian Lipworth
61
Vectura
Combining biomarkers for prognostic modelling of Parkinson's disease
Journal of Neurology, Neurosurgery, and Psychiatry
16/5/2022Conflict of interestUniversity of GlasgowUKDonald Grosset
62
Vectura
Genetics of validated Parkinson's disease subtypes in the Oxford Discovery and Tracking Parkinson's cohorts
Journal of Neurology, Neurosurgery, and Psychiatry
22/6/2022Conflict of interestUniversity of GlasgowUKDonald Grosset
63
Vectura
Echocardiographic pressure-strain loop-derived stroke work of the right ventricle: validation against the gold standard
ESC Heart FailureOct 2023Conflict of interestImperial College LondonUK
Hossein Ardeschir Ghofrani
64
Vectura
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
The Lancet. Respiratory magazine
Jan. 2022Conflict of interestUniversity of KansasUSAMario Castro
65
Vectura
Impact of Biologic Therapy on the Small Airways Asthma Phenotype
LungDec. 2022Conflict of interestUniversity of Dundee School of MedicineUKBrian Lipworth
66
Vectura
Gender gap in deep brain stimulation for Parkinson's disease
NPJ Parkinson's disease20/4/2022Conflict of interestUniversity of PaduaItalyAngelo Antonini
67
Vectura
Uncertainty analysis of chest X-ray lung height measurements and size matching for lung transplantation
Journal of thoracic diseaseApr. 2022Conflict of interestUSARamsey Hachem
68
Vectura Fertin Pharma
Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series
Med (New York)8/9/2023Conflict of interestUniversity of SydneyAustraliaJonathan Iredell
69
Fertin PharmaMedicated chewing gums with nicotine
Journal of Pharmaceutical and Biomedical Analysis
5/2/2022Research cooperationUniversity of Southern DenmarkDenmarkJessie Poulsen
Annette Bauer-Brandl
70
Syqe
The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial
European Journal of Pain12/06/2020
Conflict of interest and research cooperation
Tel Aviv University, RamBam academic hospital, TechnionIsrael Shlomo Almog
Simon Vulfsons
Elon EisenbergMiri Ogintz
71
Syqe
Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis
Drug and alcohol dependence
1/4/2024Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
72
Syqe
Product labeling accuracy and contamination analysis of commercially available cannabidiol product samples
Frontiers in pharmacology18/3/2024Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
73
Syqe
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review
JAMA Psychiatry01/01/2023Research cooperationJohns Hopkins UniversityUSARyan Vandrey
74
Syqe
Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial
JAMA Network open1/2/2023Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
75
Syqe
Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain
NeuropsychopharmacologyOct. 2023Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
76
Syqe
Likelihood of Positive Urine Screens of THC-COOH After Daily Use of Full-Spectrum Hemp Extracts Varies as a Function of Screening Criterion Used
Therapeutic Drug Monitoring
1/2/2023Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
77
Syqe
A cross-sectional survey on cannabis: Characterizing motives, opinions, and subjective experiences associated with the use of various oral cannabis products
Drug and alcohol dependence
1/4/2023Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
78
Syqe
Online survey of medicinal cannabis users: Qualitative analysis of patient-level data
Frontiers in pharmacology6/9/2022Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
79
Syqe
Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores
JAMA Network open1/6/2022Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
80
Syqe
The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol
Frontiers in pharmacology6/9/2022Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
81
Syqe
Smoking abstinence and cessation-related outcomes one month after an immediate versus gradual reduction in nicotine content of cigarettes
Preventive medicineDec 2022Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
82
Syqe
Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients
JAMA Open network2/5/2022Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
83
Syqe
Real-Time Monitoring of Cannabis and Prescription Opioid Co-Use Patterns, Analgesic Effectiveness, and the Opioid-Sparing Effect of Cannabis in Individuals With Chronic Pain
The Journal of painNov 2022Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
84
Syqe
Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial
Frontiers in psychiatry9/9/2021Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
85
Syqe
Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic pain
Internet interventions28/9/2021Conflict of interestJohns Hopkins UniversityUSARyan Vandrey
86
Syqe
Answering Dr Lee about the future role of phenome
Journal of minimally invasive gynecology
14/4/2024Conflict of interestThe Lady Davies Carmel Medical CenterIsrael Yuval Kaufman
87
Syqe
Is there an added value in more real-world cannabinoids studies?
European Journal of PainFeb. 2023Conflict of interestIsrael Institute of TechnoologyIsrael Elon Eisenberg
88
Syqe
Long-term effectiveness and safety of medical cannabis administered through the metered-dose Syqe Inhaler
Pain reports17/5/2022Research cooperationIsrael Institute of TechnoologyIsrael Elon Eisenberg
89
Syqe
Medicinal cannabis for chronic pain: The bermuda triangle of low-quality studies, countless meta-analyses and conflicting recommendations
European Journal of PainJul 2022Conflict of interestIsrael Institute of TechnoologyIsrael Elon Eisenberg
90
Syqe
Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study
Palliative & supportive careFeb 2020Conflict of interestIsrael Institute of TechnoologyIsrael Elon Eisenberg
91
Syqe
What distinguishes patients with mass social media-induced illness presenting with Tourette-like behavior from those with Tourette syndrome? Results of a prospective cohort study
European archives of psychiatry and clinical neuroscience
Feb. 2024Conflict of interestHannover Medical SchoolGermanyKirsten Müller-Vahl
92
Syqe
Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany
Pharmacopsychiatry
12/3/2024Conflict of interestHannover Medical SchoolGermanyKirsten Müller-Vahl
93
Syqe
Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature
Pharmacopsychiatry
1/3/2024Conflict of interestHannover Medical SchoolGermanyKirsten Müller-Vahl
94
Syqe
CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study
Psychiatry researchMay 2023Conflict of interestHannover Medical SchoolGermanyKirsten Müller-Vahl
95
Syqe
Tourette syndrome research highlights from 2022
F1000Research
23/10/2023
Conflict of interestHannover Medical SchoolGermanyKirsten Müller-Vahl
96
Syqe
Mass social media-induced illness presenting with Tourette-like behavior
Frontiers in psychiatry20/9/2022Conflict of interestHannover Medical SchoolGermanyKirsten Müller-Vahl
97
Syqe
European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment
European child & adolescent psychiatry
Mar. 2022Conflict of interestHannover Medical SchoolGermanyKirsten Müller-Vahl
98
Syqe
European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part I: assessment
European child & adolescent psychiatry
Mar. 2022Conflict of interestHannover Medical SchoolGermanyKirsten Müller-Vahl
99
Syqe
European clinical guidelines for Tourette syndrome and other tic disorders: summary statement
European child & adolescent psychiatry
Mar. 2022Conflict of interestHannover Medical SchoolGermanyKirsten Müller-Vahl
100
Syqe
European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: psychological interventions
European child & adolescent psychiatry
Mar. 2022Conflict of interestHannover Medical SchoolGermanyKirsten Müller-Vahl